HEPA
Hepion Pharmaceuticals, Inc.
OTCHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Gary S. Stetz
IPO Date
2014-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Hepion Pharmaceuticals, Inc.
CEO
Gary S. Stetz
IPO Date
2014-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 1,250,000 |
| $0.04 |
| 27 Apr 2026 | LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 5,000,000 | $0.04 |
| 27 Apr 2026 | LoPriore Vincent S | director, 10 percent owner, officer: Executive Chairman | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 27 Apr 2026 | Appajosyula Sireesh | director | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 27 Apr 2026 | Stetz Gary S. | director, officer: Interim CEO | P-Purchase | Acquired | 1,250,000 | $0.04 |
| 18 Mar 2026 | Stetz Gary S. | director, officer: Chief Executive Officer | Disposed | 0 | $0.00 |
| 18 Mar 2026 | LoPriore Vincent S | director, officer: Executive Chairman | Disposed | 0 | $0.00 |
| 18 Mar 2026 | Appajosyula Sireesh | director: | Disposed | 0 | $0.00 |
| 7 Mar 2024 | Purcell Michael J. | director | A-Award | Acquired | 50,000 | $0.00 |